Kaizen Financial Strategies

Position in JNJ — Johnson & Johnson

CIK 1842013 CAMPBELL, CA

Position in JNJ

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$220,191

-$2,004 QoQ

Shares Held

867

-4.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#4,440

of 4,664 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kaizen Financial Strategies holds $4,120,314 across 6 Drug Manufacturers - General names. JNJ ranks #6 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,464	$1,755,965
2	ABBV	AbbVie Inc.	4,092	$1,029,710
3	AMGN	Amgen Inc	1,393	$504,433
4	GILD	Gilead Sciences, Inc.	2,784	$351,730
5	MRK	Merck & Co., Inc.	2,010	$258,285
6	JNJ	Johnson & Johnson This page	867	$220,191

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$220,191	867	-4.6%	Shares	Sole	2026-07-30
2026-03-31	$222,195	909	—	Shares	Sole	2026-05-01
No filing history on record for this holder in this stock.